Causes clustering of PSD-95


Abbreviations: NMDAR, A-methyl-D-aspartate receptor; PSD-95, postsynaptic density protein 95; RNAi, RNA interference.

Abbreviations: NMDAR, A-methyl-D-aspartate receptor; PSD-95, postsynaptic density protein 95; RNAi, RNA interference.

members, and all unrelated controls analyzed. Support for the involvement of neuroligin 4 with autism followed from a large study of autistic individuals, where 4 missense mutations in neuroligin 4 were identified51. In agreement, a two base pair deletion in neuroligin 4, leading to a truncation in the expressed protein (position 429), was identified in a family containing both autistic and nonautistic but mentally retarded family members52. This suggested that neuroligin-associated disorders include both autism and mental retardation, and thus that these two syndromes may involve a common synaptic mechanism. However, controversy has arisen over the association of autism with neuroligin gene mutations. In two other studies involving larger populations, neuroligin mutations were not identified in association with autism53'54. Although these studies do not rule out a role for neuroligin, they suggest that it may only be responsible for a small percentage of the heterogeneous population suffering from autism55 and mental retardation56.

To further the investigation into the role that neuroligin mutations may play in nervous system disorders, constructs of neuroligins 3 and 4 encoding the previously identified disease-associated mutations R451C and D396X50, were generated and transfected into heterologous cells57,59. Only low levels of neuroligin 3 R451C (and the corresponding mutation R471C in rat neuroligin) and no neuroligin 4 D396X were targeted to the cell surface, and co-labeling revealed that both mutant proteins were retained in the endoplasmic reticulum. Upon transfection into hippocampal neurons, the mutants failed to promote presynaptic differentiation57. In a related study using an autism mutant of neuroligin 3 and a comparable mutation site in neuroligin 1, transfections resulted in less efficient trafficking to the cell surface, despite retaining some synaptogenic activity58. Although much work remains to be done to establish its role in disease, the disruption of the neuroligin/neurexin complex may significantly alter the ratio between excitatory and inhibitory neurotransmission, manifesting itself in an impaired cognitive development, and possibly psychiatric disorders such as autism.


Neuroligin and neurexin represent an ideal candidate pair for a role in the formation and/or maturation of synapses due to their heterotypic binding, regulated by alternative splicing and Ca2+ dependence. At least in vitro, neuroligin and ß-neurexin induce pre- and postsynaptic specializations, respectively, including recruitment of relevant synaptic molecules to newly formed synaptic contacts. Through its interaction with PSD-95, the complex seems to be of particular importance for the balance between excitatory and inhibitory synapses. The newly induced synaptic contacts appear functional due to the detection of neurotransmitter release, although this has only been tested by miniature postsynaptic current recordings. Disruption of the ß-neurexin/neuroligin complex in vitro, in turn, results in the abrogation of synaptic structure and function. Based on identified mutations, neuroligins and the neuroligin/ß-neurexin complex are putative candidates for the molecular basis of cognitive diseases such as autism and mental retardation.*


1. Ichtchenko, K., Hata, Y., Nguyen, T., Ullrich, B., Missler, M., Moomaw, C., and Südhof, T.C. (1995) Cell81, 435-443.

2. Ichtchenko, K., Nguyen, T., and Südhof, T.C. (1996) J Biol Chem 271, 2676-2682.

3. Boucard, A.A., Chubykin, A., Comoletti, D., Taylor, P., and Südhof, T.C. (2005) Neuron 48, 229-236.

4. Nguyen, T., and Südhof, T.C. (1997) J Biol Chem 272, 26032-26039.

5. Song, J.Y., Ichtchenko, K., Südhof, T.C., and Brose, N. (1999) Proc Natl Acad Sci U S A 96, 1100-1105.

6. Irie, M., Hata, Y., Takeuchi, M., Ichtchenko, K., Toyoda, A., Hirao, K., Takai, Y., Rosahl, T.W., and Südhof, T.C. (1997) Science 277, 1511-1515.

'The bioinformatic work for this review was supported by grant SFB406-C9 (to M.M.).

7. Missler, M., and Südhof, T.C. (1998) Trends Genet 14, 20-26.

8. Ullrich, B., Ushkaryov, Y.A., and Südhof, T.C. (1995) Neuron 14, 497-507.

9. Ushkaryov, Y.A., Petrenko, A.G., Geppert, M., and Südhof, T.C. (1992) Science 257, 50-56.

10. Ushkaryov, Y.A., Hata, Y., Ichtchenko, K., Moomaw, C., Afendis, S., Slaughter, C.A., and Südhof, T.C. (1994) JBiol Chem 269, 11987-11992.

11. Missler, M., Zhang, W., Rohlmann, A., Kattenstroth, G., Hammer, R.E., Gottmann, K., and Sudhof, T.C. (2003) Nature 424, 939-948.

12. Zhang, W., Rohlmann, A., Sargsyan, V., Aramuni, G., Hammer, R.E., Sudhof, T.C., and Missler, M. (2005) JNeurosci 25, 4330-4342.

13. Sugita, S., Saito, F., Tang, J., Satz, J., Campbell, K., and Sudhof, T.C. (2001) J Cell Biol 154, 435-445.

14. Beglopoulos, V., Montag-Sallaz, M., Rohlmann, A., Piechotta, K., Ahmad, M., Montag, D., and Missler, M. (2005) Mol Cell Biol 25, 7278-7288.

15. Missler, M., and Südhof, T.C. (1998) J Neurosci 18, 3630-3638.

16. Comoletti, D., Flynn, R., Jennings, L.L., Chubykin, A., Matsumura, T., Hasegawa, H., Sudhof, T.C., and Taylor, P. (2003) JBiol Chem 278, 50497-50505.

17. Dean, C., Scholl, F.G., Choih, J., DeMaria, S., Berger, J., Isacoff, E., and Scheiffele, P. (2003) Nat Neurosci 6, 708-716.

18. Tsigelny, I., Shindyalov, I.N., Bourne, P.E., Südhof, T.C., and Taylor, P. (2000) Protein Sci 9, 180-185.

19. Rudenko, G., Nguyen, T., Chelliah, Y., Südhof, T.C., and Deisenhofer, J. (1999) Cell 99, 93-101.

20. Kim, E., Niethammer, M., Rothschild, A., Jan, Y.N., and Sheng, M. (1995) Nature 378, 85-88.

21. Kornau, H.C., Schenker, L.T., Kennedy, M.B., and Seeburg, P.H. (1995) Science 269, 1737-1740.

22. El Husseini, A.E., Schnell, E., Chetkovich, D.M., Nicoll, R.A., and Bredt, D.S. (2000) Science 290, 1364-1368.

23. Leonard, A.S., Davare, M.A., Horne, M.C., Garner, C.C., and Hell, J.W. (1998) JBiol Chem 273, 19518-19524.

24. Hata, Y., Butz, S., and Südhof, T.C. (1996) J Neurosci 16, 2488-2494.

25. Nakagawa, T., Futai, K., Lashuel, H.A., Lo, I., Okamoto, K., Walz, T., Hayashi, Y., and Sheng, M. (2004) Neuron 44, 453-467.

26. Borg, J., Straight, S.W., Kaech, S.M., Taddeo-Borg, M., Kroon, D.E., Karnak, D., Turner, R.S., Kim, S.K., and Margolis, B. (1998) JBiol Chem 273, 31633-31636.

27. Butz, S., Okamoto, M., and Südhof, T.C. (1998) Cell 94, 773-782.

28. Biederer, T., and Südhof, T.C. (2000) JBiol Chem 275, 39803-39806.

29. Biederer, T., and Sudhof, T.C. (2001) JBiol Chem 276, 47869-47876.

30. Zhang, Y., Luan, Z., Liu, A., and Hu, G. (2001) FEBS Lett 487, 99-102.

31. Maximov, A., Sudhof, T.C., and Bezprozvanny, I. (1999) J Biol Chem 274, 24453-24456.

32. Hsueh, Y.P., Wang, T.F., Yang, F.C., and Sheng, M. (2000) Nature 404, 298-302.

33. Hsueh, Y.P., Yang, F.C., Kharazia, V., Naisbitt, S., Cohen, A.R., Weinberg, R.J., and Sheng, M. (1998) J Cell Biol 142, 139-151.

34. Scheiffele, P., Fan, J., Choih, J., Fetter, R., and Serafini, T. (2000) Cell 101, 657-669.

35. Biederer, T., Sara, Y., Mozhayeva, M., Atasoy, D., Liu, X., Kavalali, E.T., and Sudhof, T.C. (2002) Science 297, 1525-1531.

36. Sara, Y., Biederer, T., Atasoy, D., Chubykin, A., Mozhayeva, M.G., Sudhof, T.C., and Kavalali, E.T. (2005) J Neurosci 25, 260-270.

37. Graf, E.R., Zhang, X., Jin, S.X., Linhoff, M.W., and Craig, A.M. (2004) Cell 119, 1013-1026.

38. Fu, Z., Washbourne, P., Ortinski, P., and Vicini, S. (2003) JNeurophysiol 90, 3950-3957.

39. Nam, C.I., and Chen, L. (2005) Proc Natl Acad Sci US A 102, 6137-6142.

40. Chih, B., Engelman, H., and Scheiffele, P. (2005) Science 307, 1324-1328.

41. Prange, O., Wong, T.P., Gerrow, K., Wang, Y.T., and El Husseini, A.E. (2004) Proc Natl Acad Sci USA 101, 13915-13920.

42. Levinson, J.N., Chery, N., Huang, K., Wong, T.P., Gerrow, K., Kang, R., Prange, O., Wang, Y.T., and El-Husseini, A. (2005) JBiol Chem 280, 17312-17319.

43. Durand, G.M., Kovalchuk, Y., and Konnerth, A. (1996) Nature 381, 71-75.

44. Rao, A., Kim, E., Sheng, M., and Craig, A.M. (1998) J Neurosci 18, 1217-1229.

45. Dresbach, T., Neeb, A., Meyer, G., Gundelfinger, E.D., and Brose, N. (2004) Mol Cell Neurosci 27, 227-235.

46. Varoqueaux, F., Jamain, S., and Brose, N. (2004) Eur J Cell Biol 83, 449-456.

47. Levinson, J.N., and El Husseini, A.E. (2005) Neuron 48, 171-174.

48. Rubenstein, J.L., and Merzenich, M.M. (2003) Genes Brain Behav 2, 255-267.

49. Bolliger, M.F., Frei, K., Winterhalter, K.H., and Gloor, S.M. (2001) Biochem J 356, 581-588.

50. Jamain, S., Quach, H., Betancur, C., Rastam, M., Colineaux, C., Gillberg, I.C., Soderstrom, H., Giros, B., Leboyer, M., Gillberg, C., and Bourgeron, T. (2003) Nat Genet 34, 27-29.

51. Yan, J., Oliveira, G., Coutinho, A., Yang, C., Feng, J., Katz, C., Sram, J., Bockholt, A., Jones, I.R., Craddock, N., Cook Jr, E.H., Vicente, A., and Sommer, S.S. (2005) Mol Psychiatry 10, 329-335.

52. Laumonnier, F., Bonnet-Brilhault, F., Gomot, M., Blanc, R., David, A., Moizard, M.P., Raznaud, M., Ronce, N., Lemonnier, E., Calvas, P., Laudier, B., Chelly, J., Fryns, J.P., Ropers, H.H., Hamel, B.C., Andres, C., Barthelemy, C., Moraine, C., and Briault, S. (2004) Am J Hum Genet 74, 552-557.

53. Vincent, J.B., Kolozsvari, D., Roberts, W.S., Bolton, P.F., Gurling, H.M., and Scherer, S.W. (2004) Am JMed Genet B Neuropsychiatr Genet 129, 82-84.

54. Gauthier, J., Bonnel, A., St-Onge, J., Karemera, L., Laurent, S., Mottron, L., Fombonne, E., Joober, R., and Roleau, G.A. (2005) Am JMed Genet B Neuropsychiatr Genet 132, 74-75.

55. Risch, N. et al. (1999) Am J Hum Genet 65(2), 493-507.

56. Chiurazzi, P., Hamel, B.C., and Neri, G. (2001) Eur J Hum Genet 9, 71-81.

57. Chih, B., Afridi, S.K., Clark, L., and Scheiffele, P. (2004) Hum Mol Genet 13, 1471-1477.

58. Chubykin, A.A., Liu, X., Comoletti, D., Tsigelny, I., Taylor, P., and Sudhof, T.C. (2005) J Biol Chem 280, 22365-22374.

59. Comoletti, D., De Jaco, A., Jennings, L.L., Flynbn, R.E., Tsigelny, I., Ellisman, M.H., and Taylor, P. (2004) J Neurosci 24, 4889-4893.

Aspergers Answers Revealed

Aspergers Answers Revealed

Learn How to Help, Understand amp Cope with your Aspergers Child from a UK Chartered Educational Psychologist. Before beginning any practice relating to Aspergers it is highly recommended that you first obtain the consent and advice of a qualified health,education or social care professional.

Get My Free Ebook

Post a comment